NCT07269418

Brief Summary

This is a prospective, longitudinal, multicenter, observational cohort study conducted on a population of patients who underwent ligamentoplasty for an acromioclavicular dislocation and who agreed to be followed for a period of two years starting from the day of hospital discharge.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for all trials

Timeline
22mo left

Started Mar 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Mar 2024Mar 2028

Study Start

First participant enrolled

March 28, 2024

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

September 22, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 8, 2025

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2028

Last Updated

December 8, 2025

Status Verified

November 1, 2025

Enrollment Period

3.9 years

First QC Date

September 22, 2025

Last Update Submit

November 25, 2025

Conditions

Keywords

anatomic ligament reconstructionacromioclavicular disjunction

Outcome Measures

Primary Outcomes (1)

  • Acromioclavicular reduction

    The parameters measured and compared with the contralateral side will be : * The CC (coracoclavicular) distance measured on the anteroposterior Zanca view * The AC-DC distance(Acromial center line to dorsal clavicle) * The GC-PC distance (Glenoid center line to posterior clavicle) Assessment of the result of the intervention on the acromioclavicular radiological reduction 3 months post-operatively according to the quantitative radiographic parameters described by Zumstein. The reduction will be considered as: * Complete if the AC-DC and GC-PC distances on the operated side are equal to those on the healthy side, with a margin of less than 10%. * Partial if the AC-DC and GC-PC distances on the operated side are equal to those on the healthy side, with a margin between 10% and 20%. * Poor if the AC-DC and GC-PC distances on the operated side are equal to those on the healthy side, with a margin greater than 20%.

    Month 3

Secondary Outcomes (7)

  • Pain assessement

    Month 24

  • Shoulder functional assessment with the the ACJI Score (Acromioclavicular Joint Instability Score)

    Month 3

  • Return to work

    Month 24

  • Resumption of physical and sporting activities (with the Self-Constant score)

    Month 24

  • Patient satisfaction

    Month 24

  • +2 more secondary outcomes

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Patient operated on for anatomic ligament reconstruction for an acromioclavicular disjunction

You may qualify if:

  • Male or female aged 18 to 60
  • Patient who has been informed of the objectives and conditions of the study and who has not objected to participation
  • Patient who has undergone reconstruction for an acute Rockwood stage 4 or 5 acromioclavicular dislocation and for whom elbow immobilization was required for 6 weeks (self-rehabilitation in the supine position is possible from day 15, without pendulum or adduction movements).

You may not qualify if:

  • Time between trauma and ACL reconstruction greater than 10 days
  • History of surgery or trauma to the operated shoulder
  • History of acromioclavicular surgery or trauma to the contralateral shoulder
  • History of shoulder stiffness
  • Patient playing a contact sport (rugby, American football)
  • Presence of severe acromioclavicular osteoarthritis
  • Mental impairment or any other reason that may hinder understanding or strict application of the protocol
  • Patient under legal protection, guardianship, or curatorship
  • Patient already included in an interventional therapeutic trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique de l'Union

Saint-Jean, 31240, France

Location

MeSH Terms

Conditions

Joint Dislocations

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesWounds and Injuries

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 22, 2025

First Posted

December 8, 2025

Study Start

March 28, 2024

Primary Completion (Estimated)

March 1, 2028

Study Completion (Estimated)

March 1, 2028

Last Updated

December 8, 2025

Record last verified: 2025-11

Locations